Detection of an EML4-ALK fusion mutation secondary to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer: a case report - Ren, Ke-Hui; Qin, Wen-Wen; Wang, Yun; Peng, Jing-Cui; Hu, Wen-Xia (Annals of Palliative Medicine, 2022)